Trial intelligence / Profile preview

Dexmedetomidine vs Nitroglycerin in Functional Endoscopic Sinus Surgeries

NCT07585201Completed

Sponsor
Zagazig University
Start
Sep 2022
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial in intraoperative bleeding comparing Group D (Dexmedetomidine) with Group N (Nitroglycerin) (2 arms). Primary endpoints: Quality of the surgical field and Drug cost. Started Sep 2022; status: completed.

02

Drugs

dexmedetomidinenitroglycerin
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on NCT07585201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07585201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call